DRTSWAlpha Tau Medical Ltd. Warrant
4.240USDMkt Cap: —P/E: —3d ago
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid ca…
Industry Peers
Health Information Services$40.27BUSDP/E 44.0
$13.12BUSD
$11.65BUSDP/E 52.6
$8.84BUSDP/E 39.5
$8.48BUSD
$7.14BUSDP/E 10.8
$4.80BUSDP/E 35.7
$4.51BUSDP/E 30.2
$4.33BUSD
$2.70BUSDP/E 96.0
$1.62BUSDP/E 42.4
$1.47BUSD
$1.46BUSDP/E 35.7
$1.29BUSD
$1.18BUSDP/E 57.5
$1.16BUSD
$870.57MUSD
$844.16MUSDP/E 40.1
$748.70MUSDP/E 75.8
$736.36MUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-42.63M $
Revenue/Share—
Last Price4.240 USD
Fiscal Year End—
MR Quarter—
Employees121
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B8.89
EPS (TTM)—
EPS (Forward)—
52W Range
3.80098% of range4.250
52W High4.250 USD
52W Low3.800 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.29%
ROA-40.35%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.68M $
CapEx (TTM)6.08M $
FCF Margin—
FCF Yield—
Net Debt-85.49M $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.18
Current Ratio11.09
Quick Ratio10.45
Book Value/Sh0.4770 USD
Cash/Share1.090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float64.10M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.19
S&P 52W Chg19.18%
Avg Vol (30d)112.85K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—